AISeeking Alphaabout 4 hours ago
Palantir Downgraded to Hold on Valuation Risk
1 min read
Palantir received a Hold/Wait rating after Q1-FY2026, with its ~42x FY2026 sales valuation leaving little room for error. Engineering-intensive deployments cap short-term growth, while international and regulatory risks threaten expansion. Key indicators include technical headcount, U.K. NHS contract risk, and U.S. legislation.
Level
Hype check
Tap to vote and see what everyone thinks.
